20050206
 Cardinal Health Profit Falls 42% Amid Drug-Business Pressures   By Dinah Wisenberg Brin, The Wall Street Journal,  Feb 7, 2005  The Dublin, Ohio, drug wholesaler also said its audit committee has disciplined employees over accounting problems reviewed last year. The company's controller, Gary S. Jensen, is resigning effective Feb. 15 in connection with the audit committee's findings on employee responsibility for the accounting matters, Cardinal said.  Cardinal continues to experience earnings pressure as it makes a transition from a drug-distribution business model tied to increases in pharmaceutical prices to one based on more predictable fee-for- service agreements with manufacturers. In 4 p.m. composite trading Friday on the New York Stock Exchange, Cardinal was at $58.18, off $1.91.   
